Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push 
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions 
Canadian Dollar Outlook: Resilient Performance Driven by Oil Prices and Market Dynamics 
U.S. and EU Strengthen Critical Minerals Partnership to Reduce China Dependence 
Dollar Weakens Amid Middle East Tensions and Anticipated Central Bank Decisions 
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Dollar Holds Firm as Middle East Tensions and Central Bank Decisions Keep Markets on Edge 
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns 
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown 
Araqchi Leads Iran’s Diplomatic Push as U.S. Talks and Oil Market Tensions Rise 
Asian Currencies Rise Ahead of BOJ and Fed Meetings as Dollar Softens 
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 
Japanese beer and beverage maker Kirin is selling its China soft drinks joint venture to a Chinese investment fund, Plateau Consumer, for $994 million to enhance its pharmaceutical business.
The sale covers Kirin’s entire 40 percent stake in China Resources Kirin Beverages.
Established in 2011, China Resources Kirin Beverage had been expanding its business in China, making bottled water and bottled tea.
The move was part of its recent decision to review its investment portfolio, including foreign operations, under a management plan that runs through 2024. It comes shortly after Kirin decided to pull out of a joint venture brewery in Myanmar.
Kirin is focusing on certain areas, including pharmaceuticals and health science as well as food and beverages.
The Tokyo-based company has been streamlining its operations to focus on pharmaceutical projects like developing drugs for diseases that have no existing treatments and working on what it calls LC-Plasma to offer products that help maintain immune systems.
Kirin is among Japan’s top beer brands, and still has various global operations, including Four Roses Distillery in the U.S. and San Miguel Brewery in the Philippines.
.
